Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters

International Journal of Gynecological Cancer

Volumn 16, Issue 1, 2006, Pages 402-408

  Kayaselcuk, F ^a   Erkanli, S ^a   Bolat, F ^a   Seydaoglu, G ^b   Kuscu, E ^a   Demirhan, B ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Cyclin H; Endometrial carcinoma; Hyperplasia

Indexed keywords

BIOLOGICAL MARKER; BIOTIN; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLIN H; CYCLINE; FORMALDEHYDE; PARAFFIN; PROTEIN DERIVATIVE; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE;

BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN E; CYCLINS; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TISSUE CULTURE TECHNIQUES; TUMOR MARKERS, BIOLOGICAL;

EID: 33645361712     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00407.x     Document Type: Article

References (22)

1. Parker SL Tong T Bolden S Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996 46 5 27.
2. Kyushima N Watanabe J Hata H Jobo T Kameya T Kuramoto H. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 2002 128 307 12.
3. Ferrandina G Legge F Ranelletti FO et al. Cyclooxygenase-2 expression in endometrial carcinoma. Correlation with clinicopathological parameters and clinical outcome. Cancer 2002 95 801 7.
4. Bahman S Lovell AJ Adel EN Juan CF Jay G Michael FP. Amplification and overexpression of HER-2/neu (c-erb2) in endometrial cancers. Correlation with overall survival. Cancer Res 1995 55 5693 8.
5. Bai MK Costopoulos JS Christoforidou BP Papadimitriou CS. Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. Oncology 1994 51 314 9.
6. Quddus MR Latkovich P Castellani WJ et al. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. Arch Pathol Lab Med 2002 126 459 63.
7. Salvesen HB Iversen OE Akslen LA. Prognostic significance of angiogenesis and Ki-67, p53 and p21 expression: a population-based endometrial carcinoma study. J Clin Oncol 1999 17 1382 90.
8. Bamberger AM Milde-Langosch K Rössing E Goemann C Löning T. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 2001 127 545 50.
9. Oshita T Shigemasa K Nagai N Ohama K. P27, cyclin E, and CDK2 expression in normal and cancerous endometrium. Int J Oncol 2002 21 737 43.
10. Milde-Langosch K Bamberger AM Goemann C et al. Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathological parameters. J Cancer Res Clin Oncol 2001 127 537 44.
11. Morgan DO. Principles of CDK regulation. Nature 1995 374 131 4.
12. Virmani A Rathi A Heda S et al. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancer. Int J Cancer 2003 107 341 5.
13. Gillett C Fantl V Smith R et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994 54 1812 7.
14. Faust M Kartarius S Schwindling SL Montenarh M. Cyclin H is a new binding partner for protein kinase CK2. Biochem Biophys Res Commun 2002 296 13 9.
15. Yamaguchi M Kato H Yoshida S Yamamura S Uchimiya H Umeda M. Control of in vitro organogenesis by cyclin-dependent kinase activities in plants. Proc Natl Acad Sci U S A 2003 100 8019 23.
16. Masaki T Shiratori Y Rengifo W et al. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003 37 534 43.
17. FIGO news. Int J Gynecol Obstet 1989 28 189 93.
18. Shiozawa T Xin L Nikaido T Fujii S. Immunohistochemical detection of cyclin A with reference p53 expression in endometrial endometrioid carcinomas. Int J Gynecol Pathol 1997 16 348 53.
19. Kallakury BV Ambros RA Hayner-Buchan AM Sheehan CE Malfetano JH Ross JS. Cell proliferation - associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes. Int J Gynecol Pathol 1998 17 320 6.
20. Shiozawa T Li SF Nakayama K Nikaido T Fujii S. Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki-67 in normal endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod 1996 2 745 52.
21. Hayashi K Yokozaki H Naka K et al. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. Cancer Lett 2000 151 199 208.
22. Sawiris GP Sherman-Baust CA Becker KG Cheadle C Teichberg D Morin PC. Development of a highly specialized c DNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res 2002 62 2923 8.